[Marketwire] - A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012. The iShares NASDAQ Biotechnology Index , the SPDR S&P Biotech ETF ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment